CollPlant Biotechnologies Ltd.
PublicCollPlant Biotechnologies Ltd. is now publicly traded
The data on this page reflects CollPlant Biotechnologies Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jul 20, 2026
Total Funding Raised
$10.4M
Company Overview
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company that develops products based on its proprietary recombinant human collagen (rhCollagen) for 3D bioprinting of tissues and organs, medical aesthetics, and advanced wound care.
Sector
Healthcare
AI Layer
Non-AI
Keywords
CollPlant Biotechnologies Ltd. Comparables
Compare CollPlant Biotechnologies Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiber Technologies AB | 66% | |
| RenovoDerm | 45% | |
| Laboratoires Arion | 42% |
CollPlant Biotechnologies Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 20, 2026 |
Key People
Founding team and executive leadership
CollPlant Biotechnologies Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access